JENNIFER LUONG: Open Payments
NPI 1235897190 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,146 in 96 payments from 15 companies in 2025. Trend: 2023 $1,236 · 2024 $2,974 · 2025 $2,146
Food & beverage: $2,146
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $384 |
| ABBVIE INC. | 16 | $304 |
| Novartis Pharmaceuticals Corporation | 16 | $295 |
| Lilly USA, LLC | 12 | $239 |
| PFIZER INC. | 9 | $176 |
| Radius Health, Inc. | 5 | $163 |
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| Amgen Inc. | 6 | $147 |
| Janssen Biotech, Inc. | 3 | $89 |
| Aurinia Pharma U.S., Inc. | 2 | $51 |
Products named: BENLYSTA, COSENTYX, TALTZ, RINVOQ, XELJANZ, Tymlos, SAPHNELO, SKYRIZI.
Industry payments across CA — which companies pay providers there.
